Riskpilot← Back to searchSign inGet full accessM&M Orthopedic Consult AB
ABActiveOrg 5569701922Qvensås 12General medical practice activities · NACE 8621Est. 20140 employees
Revenue 2024
SEK 163K
EBITDA margin
82.8%
Equity ratio
100.0%
Financial strength
Net profit 2024
SEK 107K
0 employees
| Revenue | SEK 163K | — |
| EBITDA | SEK 135K | — |
| Net profit | SEK 107K | — |
| Total assets | SEK 157K | — |
| Equity | SEK 157K | — |
| Employees | 0 | — |
Legal name
M&M Orthopedic Consult AB
Org number
5569701922
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
29 april 2014
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget skall genomföra läkaruppdrag omfattande medicinsk bedömning, rådgivning och behandling. Bolaget skall också driva medicinsk utbildning och undervisning. Därtill skall bolaget även äga och förvalta värdepapper, fast egendom och därmed förenlig verksamhet.
Address
Qvensås 12
Email
m_bodenaes@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 100 | — | 0 | — | 163 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 80 | 0 | 175 | 0 | 135 |
| Depreciation & amort. | −0 | — | −0 | — | −0 |
| EBIT | 80 | 0 | 175 | 0 | 135 |
| Net financials | — | — | — | — | — |
| Profit before tax | 80 | 0 | 176 | 0 | 135 |
| Tax | −17 | — | −39 | — | −28 |
| Net profit | 63 | — | 137 | — | 107 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 113 | — | 187 | — | 157 |
| Equity | 113 | — | 187 | — | 157 |
| Long-term debt | 0 | — | 0 | — | 0 |
| Short-term debt | 0 | — | 0 | — | 0 |
| Total debt | — | — | — | — | — |
EBITDA margin
82.8%
This company
15.8%
Market median
+424% vs market
20202024
Equity ratio
100.0%
This company
38.2%
Market median
+162% vs market
20202024
Return on equity
68.2%
This company
18.4%
Market median
+271% vs market
20202024
Net profit margin
65.6%
This company
8.1%
Market median
+710% vs market
20202024
Asset turnover
1.04×
This company
1.12×
Market median
+7% vs market
20202024
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
JM Chief Executive Officer | Chief Executive Officer | 2022 |
NO Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2022 |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of M&M Orthopedic Consult AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jan Magnus Bodenäs | Chief Executive Officer | 0 companies |
| Nils Olof Magnus Nimmermark | Deputy Chief Executive Officer | 0 companies |